Health & Biotech
Stories by Tim Boreham
Health & Biotech
Dr Boreham’s Crucible: With five trials and $100m, cancer-hunter Clarity’s future is clear
Health & Biotech
Health Kick: Wellnex CEO George Karafotias discusses the company’s wellness pivot, major licensing deal and new product suite
Health & Biotech
Health Kick Podcast: HitIQ has a revolutionary solution for the concussion problem in contact sports
Health & Biotech
Health Kick: Prescient Therapeutics’ YTD share price soars +220% after progress in clinical studies and CAR-T platform
Health & Biotech
Dr Boreham’s Crucible: With growing pains behind it, is PainChek ready to grow?
Health & Biotech
Dr Boreham’s Crucible: Who’s winning and losing in the life sciences IPO Olympiad?
Health & Biotech
Dr Boreham’s Crucible: Can Lumos (ASX:LDX) light up the US with FDA approval?
Health & Biotech
Dr Boreham’s Crucible: Don’t cry for me, Argenica
Health & Biotech
Dr Boreham’s Crucible: Time to make a song and dance about Actinogen (ASX:ACW)?
Tech
Health Kick: New ASX listee Audeara uses algorithms to create perfect audio and better hearing health
Health & Biotech